Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

NCT00845429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

729

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Orthomyxoviruses
Myxovirus Infection

Interventions

BIOLOGICAL: Influenza virus vaccine - cell based (2007-2008 Formulation)
BIOLOGICAL: Influenza virus vaccine - cell-based (2007-2008 Formulation)
BIOLOGICAL: Influenza virus vaccine (2007-2008 Formulation)

Sponsor

Sanofi